CALCA and migraine disorder: Because antibody has a low volume ofdistribution, and the anti-CGRP antibodies mainly act by reducing the circulatinglevel of CGRP or CGRP signaling in cells that are in close proximity of the vascularsystem [36, 96, 98, 99], there remains a large unmet medical needof therapies for patients with severe migraine.